San Diego-centered Viking Therapeutics marked by itself as a serious competitor from the weight loss drug market place in February just after revealing promising facts from the mid-stage trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given as a weekly injection and in March the company unve… Read More